ReviewThe MAK collection for occupational health and safety2025
Cadmium and its inorganic compounds - Addendum: re-evaluation of the BLW: Assessment Values in Biological Material - Translation of the German version from 2025.
Review in The MAK collection for occupational health and safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Naphthalene: MAK Value Documentation, addendum - Translation of the German version from 2022.The MAK collection for occupational health and safety · 2025Article
- Renal excretion of 1,2-dihydroxynaphthalene (DHN) in firefighting instructors after exposure to polycyclic aromatic hydrocarbons (PAHs) during live fire training.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The German Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) re-evaluated the data for cadmium [7440-43-9] to derive a biological guidance value (BLW) for its systemic non-carcinogenic end points. Relevant studies were identified from a literature search. Exposure to cadmium dust can cause nasal inflammation and anosmia, bronchitis and pneumonia, which are recognised as local effects. Tubular kidney damage was identified as the most sensitive end point of systemic toxicity, which results in excretion of low molecular weight proteins such as α1 and β2-microglobulins and retinol binding protein (RBP) in the urine. Recent studies on workers occupationally exposed to cadmium revealed a NOEL (no observed effect level) and a BMDL5 (benchmark dose lower limit) for tubular proteinuria at approximately 3 to 5 µg cadmium/g creatinine in ever-smokers, whereas this threshold is higher in never-smokers. Therefore, a BLW of 2 µg cadmium/g creatinine is set for cadmium in urine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.